| Dr Erin Trahan Pratt, MD | |
|
101 Rue Fontaine Bldg 2, Lafayette, LA 70508-5744 | |
| (337) 484-1414 | |
| (337) 233-3188 |
| Full Name | Dr Erin Trahan Pratt |
|---|---|
| Gender | Female |
| Speciality | Allergy/immunology |
| Experience | 12 Years |
| Location | 101 Rue Fontaine Bldg 2, Lafayette, Louisiana |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1124297627 | NPI | - | NPPES |
| MD.201624 | Other | LA | STATE LICENSE NUMBER |
| 1508390 | Medicaid | LA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207K00000X | Allergy & Immunology | MD.201624 (Louisiana) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Lafayette General Medical Center | Lafayette, LA | Hospital |
| Opelousas General Health System | Opelousas, LA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Acadiana Allergy, Asthma And Immunology Center, Llc | 7416254867 | 2 |
News Archive
Derma Sciences, Inc., a medical device and pharmaceutical company focused on advanced wound care, and Quick-Med Technologies, Inc., a life sciences company that is developing innovative technologies for the healthcare and consumer markets, announce the signing of an agreement whereby Quick-Med Technologies has granted Derma Sciences an exclusive global license to intellectual property related to the novel NIMBUS antimicrobial technology, which is available in BIOGUARD dressings.
Inflammation can be thought of as taking two major forms: acute or chronic. Acute inflammation, which can be painful, usually arises quickly and resolves quickly. It accompanies bacterial infections, traumatic injury and is useful to fight infections and promote healing.
Lundbeck LLC today announced that the U.S. Food and Drug Administration has accepted for review a New Drug Application (NDA) for its investigational therapy intravenous carbamazepine, an intravenous formulation of the anti-epileptic drug (AED) carbamazepine. An action letter is anticipated before the end of 2014. Carbella is the proposed U.S. trade name for intravenous carbamazepine.
Cordis Corporation ("Cordis") announced today that it has reached an agreement with Boston Scientific ("Boston") resolving its Palmaz infringement suit relating to Boston's NIR stent, settling several other cardiology-related cases relating to patents in the Ding, Kastenhofer, Palmaz, and Fontirroche patent families, and exchanging paid-up licenses for certain intellectual properties.
› Verified 4 days ago
| Entity Name | Acadiana Allergy, Asthma And Immunology Center, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1508227604 PECOS PAC ID: 7416254867 Enrollment ID: O20160330000073 |
News Archive
Derma Sciences, Inc., a medical device and pharmaceutical company focused on advanced wound care, and Quick-Med Technologies, Inc., a life sciences company that is developing innovative technologies for the healthcare and consumer markets, announce the signing of an agreement whereby Quick-Med Technologies has granted Derma Sciences an exclusive global license to intellectual property related to the novel NIMBUS antimicrobial technology, which is available in BIOGUARD dressings.
Inflammation can be thought of as taking two major forms: acute or chronic. Acute inflammation, which can be painful, usually arises quickly and resolves quickly. It accompanies bacterial infections, traumatic injury and is useful to fight infections and promote healing.
Lundbeck LLC today announced that the U.S. Food and Drug Administration has accepted for review a New Drug Application (NDA) for its investigational therapy intravenous carbamazepine, an intravenous formulation of the anti-epileptic drug (AED) carbamazepine. An action letter is anticipated before the end of 2014. Carbella is the proposed U.S. trade name for intravenous carbamazepine.
Cordis Corporation ("Cordis") announced today that it has reached an agreement with Boston Scientific ("Boston") resolving its Palmaz infringement suit relating to Boston's NIR stent, settling several other cardiology-related cases relating to patents in the Ding, Kastenhofer, Palmaz, and Fontirroche patent families, and exchanging paid-up licenses for certain intellectual properties.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Erin Trahan Pratt, MD 101 Rue Fontaine Bldg 2, Lafayette, LA 70508-5744 Ph: (337) 484-1414 | Dr Erin Trahan Pratt, MD 101 Rue Fontaine Bldg 2, Lafayette, LA 70508-5744 Ph: (337) 484-1414 |
News Archive
Derma Sciences, Inc., a medical device and pharmaceutical company focused on advanced wound care, and Quick-Med Technologies, Inc., a life sciences company that is developing innovative technologies for the healthcare and consumer markets, announce the signing of an agreement whereby Quick-Med Technologies has granted Derma Sciences an exclusive global license to intellectual property related to the novel NIMBUS antimicrobial technology, which is available in BIOGUARD dressings.
Inflammation can be thought of as taking two major forms: acute or chronic. Acute inflammation, which can be painful, usually arises quickly and resolves quickly. It accompanies bacterial infections, traumatic injury and is useful to fight infections and promote healing.
Lundbeck LLC today announced that the U.S. Food and Drug Administration has accepted for review a New Drug Application (NDA) for its investigational therapy intravenous carbamazepine, an intravenous formulation of the anti-epileptic drug (AED) carbamazepine. An action letter is anticipated before the end of 2014. Carbella is the proposed U.S. trade name for intravenous carbamazepine.
Cordis Corporation ("Cordis") announced today that it has reached an agreement with Boston Scientific ("Boston") resolving its Palmaz infringement suit relating to Boston's NIR stent, settling several other cardiology-related cases relating to patents in the Ding, Kastenhofer, Palmaz, and Fontirroche patent families, and exchanging paid-up licenses for certain intellectual properties.
› Verified 4 days ago
Dr. Alexandra Joseph Chastant, MD Allergy & Immunology Medicare: Not Enrolled in Medicare Practice Location: 320 Settlers Trace Blvd, Lafayette, LA 70508 Phone: 337-981-9495 Fax: 337-981-7451 | |
Mr. Bernard C Fruge Jr., MD Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 320 Settlers Trace Blvd, Lafayette, LA 70508 Phone: 337-981-9495 Fax: 337-981-7451 | |
Dr. Bina E Joseph, MD Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 320 Settlers Trace Blvd, Lafayette, LA 70508 Phone: 337-981-9495 Fax: 337-981-7451 | |
Dr. Wilton Lee Bergeron, M. D. Allergy & Immunology Medicare: Not Enrolled in Medicare Practice Location: 1505 Westgate Rd, Lafayette, LA 70506 Phone: 337-981-2588 | |
Dr. Elizabeth Bertucci Robertson, M.D. Allergy & Immunology Medicare: Medicare Enrolled Practice Location: 200 Petroleum Dr, Lafayette, Lafayette, LA 70508 Phone: 337-988-9999 Fax: 337-984-7003 | |
Elizabeth Renee Smith, M.D. Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 101 Rue Fontaine Bldg 2, Lafayette, LA 70508 Phone: 337-484-1414 Fax: 337-233-3188 |